From: Adoptive immunotherapy with MUC1-mRNA transfected dendritic cells and cytotoxic lymphocytes plus gemcitabine for unresectable pancreatic cancer
Adverse event
Number of patients
%
Leukocytes
11
26.2
Neutrophils
13
31
Platelets
1
2.4
Hemoglobin
5
11.9
AST
ALT
Fatigue
Anorexia
6
14.3
Diarrhea
3
7.1
Mucositis/stomatitis
Nausea
Vomiting